晚年抑郁与多病共存及多重用药的关联:一项横断面研究
该横断面研究基于2012年基层医疗数据,比较了≥60岁抑郁患者、其他精神心理诊断患者及精神健康对照者的慢病与用药情况。且抑郁患者较其他精神心理诊断患者慢性用药率及多重用药风险也更高(PR 1.26;OR 1.75;均P<0.001)。
要点
- 晚年抑郁患者多病共存风险较精神健康对照者高(OR 1.55)。
- 晚年抑郁患者多重用药风险较对照者高(OR 2.89)。
- 抑郁患者较其他精神心理诊断患者多重用药风险更高(OR 1.75)。
核心结论
- 基层医疗中晚年抑郁与更多慢性用药相关,且超出共病躯体疾病增加所能解释的程度。
- 建议全科医生考虑进行药物审查,以防止这些患者出现不必要的药物相关问题。
研究设计与样本
- 横断面观察性研究,使用2012年基层医疗数据。
- 纳入4477例患者:抑郁患者1512例、其他精神心理诊断患者1457例、精神健康对照者1508例,按年龄和性别匹配。
- 合并疾病与处方数据,采用回归分析评估抑郁与慢性病及慢性用药的关联。
主要发现
- 抑郁患者较对照者慢性躯体病患病率高16%(PR 1.16;95%CI 10%-24%),多病共存风险更高(OR 1.55;95%CI 1.33-1.81)。
- 抑郁患者与其他精神心理诊断患者之间无差异。
- 抑郁患者较对照者慢性用药率高46%(95%CI 39%-53%),多重用药风险更高(OR 2.89;95%CI 2.41-3.47)。
- 抑郁患者较其他精神心理诊断患者慢性用药率更高(PR 1.26;P<0.001),多重用药风险更高(OR 1.75;P<0.001)。
临床怎么用
- 全科医生应关注晚年抑郁患者的慢性用药与多重用药情况。
- 可考虑对晚年抑郁患者进行药物审查,以减少不必要的药物相关问题。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Late-life depression often coincides with chronic somatic diseases and, consequently, with polypharmacy, which may complicate medical treatment. OBJECTIVE: To determine the associations between patients diagnosed with late-life depression in primary care and multimorbidity and polypharmacy. METHODS: This cross-sectional observational study was performed using 2012 primary care data. Depressed patients aged ≥60 years were compared to age and gender matched patients diagnosed with other psychological diagnoses and mentally healthy controls. Morbidity and prescription data were combined, and regression analyses were performed for the associations between depression and chronic disease and chronic drug use. RESULTS: We included 4477 patients; 1512 had a record of depression, 1457 of other mental health or psychological diagnoses and 1508 were controls. Depressed patients had a 16% [Prevalence Ratio (PR) 1.16; 95% confidence interval (95% CI) 10%-24%] higher rate of chronic somatic disease and higher odds for multimorbidity (OR 1.55; 95% CI 1.33-1.81) compared with controls. No differences existed between depressed patients and patients with other psychological diagnoses. Compared with controls, depressed patients had a 46% (95% CI 39-53%) higher rate of chronic drug use and higher odds for polypharmacy (OR 2.89; 95% CI 2.41-3.47). Depressed patients also had higher rates of chronic drug use and higher odds for polypharmacy compared with patients with other psychological diagnoses (PR 1.26; OR 1.75; both P < 0.001). CONCLUSIONS: Late-life depression in primary care patients is associated with more chronic drug use, even beyond the increased rates of comorbid somatic diseases. General practitioners should consider medication reviews to prevent unnecessary drug-related problems in these patients.
引用
- Holvast F, van Hattem BA, Sinnige J, et al. Late-life depression and the association with multimorbidity and polypharmacy: a cross-sectional study. Fam Pract. 2017. PMID: 28369380. doi:10.1093/fampra/cmx018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。